Delivery Order SPE2DB20D3101-SPE2DB25FRWU9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Spikevax 2024-25 vaccine (12 years and up) in 0.5ML syringes, with a ceiling value of $1,177.48 and completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction reflecting the agency's procurement of influenza vaccines to support military healthcare operations. The order was placed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for $7,227.30 to supply Spikevax 2025-26 vaccine (12 years and older) in 0.5 mL syringes. This is a firm fixed price delivery order with no set-aside designation, reflecting open competitive procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 20, 2025. As a child contract, this delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,431.78 on June 18, 2025, for the supply of Spikevax 2024-25 vaccine (12 years and older) in 0.5 mL syringes. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 11, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,336.38 on September 18, 2025, for SPIKEVAX 2025-26 vaccine doses (12 years and up) in 0.5mL syringes. The contract carries a firm fixed price and is scheduled for completion by October 9, 2025. This non-set-aside award is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, reflecting the company's role as a critical pharmaceutical distributor supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SPIKEVAX 2024-25 vaccine (12 years and up), 0.5ml syringes, with a ceiling value of $5,887.40. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a competitive award with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $6,512.80 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Spikevax 2025-26 vaccine (6 months to 11 years) in 0.25 mL syringes. This is a firm fixed price delivery order with no set-aside designation, competitively awarded and scheduled for completion by September 26, 2025. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $8,672.76 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine doses (0.5mL syringes for ages 12 and up) on September 15, 2025, with completion expected by October 6, 2025. This firm fixed-price, non-set-aside contract represents a discrete purchase under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be supplied from the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $2,096.74 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of SPIKEVAX 2025-26 (12 years and up) in 0.5ml syringes. This is a firm fixed price, non-set-aside contract with a completion date of October 20, 2025, to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under a larger indefinite delivery contract vehicle, enabling the pharmaceutical...
- The Defense Logistics Agency awarded a $1,177.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for Spikevax 2024-25 vaccine (12 years and up) in 0.5ml syringes, with an ultimate completion date of October 3, 2025. This is a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $7,227.30 delivery order to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and older), 0.5mL syringes, with an ultimate completion date of September 29, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC)...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRWU9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of Spikevax 2025-26 vaccine (12 years and older) in 0.5 mL syringes, valued at $7,227.30. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 20, 2025, with performance based at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle extending through December 2026 that serves as the primary pharmaceutical supply mechanism for federal military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical vendor for federal medical procurement and regularly fulfills vaccine and pharmaceutical supply requirements for the Defense Health Agency and other government healthcare systems. As a competitively positioned prime contractor on the DLA's comprehensive pharmaceutical supply contracts, the company maintains the capability to deliver a broad range of medical commodities to support military healthcare programs globally. This specific vaccine delivery order reflects the continued federal procurement of COVID-19 boosters for the military health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 9/27/25 |